Leif Ludwig is named EMBO Young Investigator
The European Molecular Biology Organization has selected Leif. S. Ludwig from the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center to become an EMBO Young Investigator. The program provides support to outstanding young life scientists.
Biochemist and physician Dr. Leif S. Ludwig (40), head of the Stem Cell Dynamics and Mitochondrial Genomics Group at the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center, is one of 26 life scientists to be newly elected into the EMBO Young Investigator Programme. EMBO is one of Europe’s largest and most important organizations in the field of molecular biology.
“This is a great recognition for my team and the work we do. The program offers direct access to a Europe-wide network of outstanding scientists, thus enabling us to carry out joint projects,” says Ludwig. “I am very much looking forward to exchanging ideas with other young group leaders across Europe. In addition to research funding, the program also provides numerous other benefits, especially for the researchers in my lab.”
About Leif Ludwig
Beginning in 2003, Leif Si-Hun Ludwig studied biochemistry at Freie Universität Berlin and then human medicine at Charité – Universitätsmedizin Berlin. As a doctoral candidate in biochemistry, he conducted research at the Whitehead Institute of Biomedical Research from 2011 to 2015 and as a postdoctoral researcher at the Broad Institute of MIT and Harvard from 2016 to 2020, both in Cambridge, Massachusetts, in the United States. Since November 2020, he has been an Emmy Noether Group Leader in the joint focus area “Single-Cell Approaches for Personalized Medicine” of the Berlin Institute of Health at Charité (BIH), the Berlin Institute for Medical Systems Biology of the Max Delbrück Center for Molecular Medicine (MDC-BIMSB), and Charité. His laboratory is based at MDC-BIMSB. Ludwig has received multiple awards for his research, including the Hector Research Career Development Award in 2021 and the Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers and the Heinz Maier-Leibnitz Prize in 2023.
About the EMBO Young Investigator Programme
The European Molecular Biology Organization (EMBO) is an international organization of life scientists, which has more than 2,000 members elected by peers. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work.
EMBO Young Investigators are outstanding researchers who have set up their first laboratories in the past four years. They join a large network of current and past Young Investigators. The researchers receive a range of benefits, including a financial award of €15,000 and training and mentoring opportunities. They also gain access to funding for themselves and their lab members to attend conferences.
Weitere Informationen:
https://www.bihealth.org/en/notices/leif-ludwig-is-named-embo-young-investigator
Korrekturen
05.12.2023 16:32
Die Pressemitteilung wurde verfasst von Katharina Kalhoff.
Die semantisch ähnlichsten Pressemitteilungen im idw
